Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 19/20 | 0.56 |
| ▸ | MAPK11 | Q15759 | 4/20 | 0.52 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.44 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.44 |
| ▸ | STRADA | Q7RTN6 | 1/20 | 0.44 |
| ▸ | BRD4 | O60885 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6472885 | 0.93 | MAPK14 (0.48) | MAPK14MAPK11ROCK2MAPK12STRADA | |
| Hydrochloric Acid SCHEMBL6471693 | 0.93 | MAPK14 (0.48) | MAPK14MAPK11ROCK2MAPK12STRADA | |
| SCHEMBL6471371 | 0.92 | MAPK14 (0.55) | MAPK14MAPK11ROCK2MAPK12STRADA | |
| SCHEMBL6471375 | 0.92 | MAPK14 (0.48) | MAPK14MAPK11ROCK2MAPK12STRADA | |
| SCHEMBL6471677 | 0.92 | MAPK14 (0.46) | MAPK14MAPK11ROCK2MAPK12STRADA | |
| SCHEMBL6473202 | 0.91 | MAPK14 (0.49) | MAPK14MAPK11ROCK2MAPK12STRADA | |
| SCHEMBL6471464 | 0.90 | MAPK14 (0.55) | MAPK14MAPK11ROCK2MAPK12STRADA | |
| SCHEMBL6474827 | 0.89 | MAPK14 (0.45) | MAPK14MAPK11ROCK2MAPK12STRADA | |
| SCHEMBL6472561 | 0.89 | MAPK14 (0.53) | MAPK14MAPK11ROCK2MAPK12STRADA | |
| SCHEMBL6474524 | 0.89 | MAPK14 (0.44) | MAPK14MAPK11ROCK2MAPK12STRADA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3691620-A1 | P38 KINASE INHIBITORS REDUCE DUX4 AND DOWNSTREAM GENE EXPRESSION FOR THE TREATMENT OF FSHD | Fulcrum Therapeutics, Inc. (US) | 2020-08-12 | — | — | EP | disclosed |
| WO-2019071147-A1 | P38 KINASE INHIBITORS REDUCE DUX4 AND DOWNSTREAM GENE EXPRESSION FOR THE TREATMENT OF FSHD | Fulcrum Therapeutics, Inc. (US) | 2019-04-11 | — | — | WO | disclosed |
| EP-1490064-B1 | SUBSTITUTED PYRIDINONES AS MODULATORS OF P38 MAP KINASE | PHARMACIA CORP (US) | 2009-11-18 | — | — | EP | disclosed |
| WO-2005018557-A2 | SUBSTITUTED PYRIDINONES | PHARMACIA CORPORATION (US) | 2005-03-03 | — | — | WO | disclosed |